Filter
440
Filtered Results: 440
Text search:
European
Centre
for
Disease
Prevention
and
Control
ECDC
Featured
Recommendations
41
New Publications
81
Language
Document type
No document type
184
Guidelines
83
Studies & Reports
80
Fact sheets
28
Manuals
20
Strategic & Response Plan
10
Situation Updates
9
Infographics
7
Resource Platforms
6
Training Material
5
Online Courses
4
Brochures
2
Videos
2
Countries / Regions
Western and Central Europe
81
Germany
18
Ukraine
18
Eastern Europe and Central Asia
16
Eastern Europe
16
Africa
7
Global
6
Guinea
5
Madagascar
5
West and Central Africa
5
Latin America and the Carribbean
5
Russia
5
Sierra Leone
4
Liberia
4
Brazil
4
Mozambique
3
Nigeria
2
Congo, Democratic Republic of
2
Guinea-Bissau
2
North Macedonia
2
Colombia
2
Myanmar / Burma
2
East and Southern Africa
2
Middle East and North Africa
2
Paraguay
2
Albania
2
Estonia
2
Romania
2
Spain
2
Burkina Faso
1
Senegal
1
Mali
1
Côte d’Ivoire / Ivory Coast
1
Cameroon
1
Ghana
1
Niger
1
Haiti
1
South Sudan
1
Turkey
1
Rwanda
1
Benin
1
Libya
1
Angola
1
South–East Asia Region
1
Western Pacific Region
1
Asia
1
Venezuela
1
Italy
1
Armenia
1
Congo-Brazzaville
1
Tajikistan
1
Bulgaria
1
Moldova
1
Uzbekistan
1
Georgia
1
Turkmenistan
1
Denmark
1
France
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
81
Clinical Guidelines
20
Key Resources
19
Public Health
11
Capacity Building
3
Women & Child Health
2
Pharmacy & Technologies
1
Toolboxes
COVID-19
90
HIV
58
AMR
57
Rapid Response
56
TB
47
Zika
25
Ebola
24
Refugee
21
Conflict
18
Planetary Health
12
Mental Health
6
Global Health Education
4
NTDs
4
Specific Hazards
3
Cholera
2
Caregiver
2
Pharmacy
2
Polio
1
Natural Hazards
1
Health Financing Toolbox
1
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence ... trends
- Chapter 3: Drug-related harms and responses
- Annex: National data tables
Available in 24 languages on:
http://www.emcdda.europa.eu/publications/edr/trends-developments/2018
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as drug policy ... responses. Together with the online Statistical Bulletin and 30 Country Drug Reports, it makes up the 2019 European Drug Report package.
Available in different languages: http://www.emcdda.europa.eu/publications/edr/trends-developments/2019_en
The current document is anupdate of the guidelines developed by the EUCAST subcommittee on detection of resistance mechanisms. The EUCAST Steering Committee has carried out the current update. The document has been developed mainly for routine use i...
EU Compass for Action on Mental Health and Well-being
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infec...
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nC...
The frequency of infectious disease epidemics is increasing, and the role of the health sector in the management of epidemics is crucial in terms of response. In the context of infectious ... epidemics, the use of climate-informed early warning systems (EWS) has the potential to increase the effectiveness of disease control by intervening before or at the beginning of the epidemic curve, instead of during the downward slope.
Currently, the initiation of interventions is heavily reliant on routine disease surveillance systems – data that often arrive too late for preventative response. However, forecasting of disease outbreaks using surveillance and weather information shows promising potential – there also remains further scope to examine seasonal climate forecasts. By combining these elements in new EWS based on computational models, it will be possible to improve both the timeliness and impact of disease control. The World Health Organization (WHO) is strengthening existing surveillance systems for infectious diseases to enable the development of more robust and timely EWS, which has resulted in the rapid development and innovation of EWS for disease outbreaks.
This manual addresses all the issues. It focus on the cycle of microbes, antibiotics, vaccination, AMR,
infection prevention and control. It will ...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hep...
Surveillance, case investigation and contact tracing for monkeypox: interim guidance 24 June 2022
recommended
The overall goal of surveillance, case investigation and contact tracing in this context is to stop human-to-human transmission to control the outbreak. The key objectives of surveillance ... case investigation are to rapidly identify cases and clusters in order to provide optimal clinical care; to isolate cases to prevent further transmission; to identify, manage and follow up contacts to recognize early signs of infection; to protect frontline health workers; to identify risk groups; and to tailor effective control and prevention measures.
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa...
10–11 May 2016, Catania, Italy
Perspectives on Drugs
Issue Brief Marburg virus disease (MVD)
recommended
Issue Brief No. 40 provides healthcare professionals with the most relevant treatment guidelines, prevention measures and training material on MVD
Nature Reviews Microbiology Vol. 17 (2019)pp.51-62
Antimicrobial susceptibility testing (AST) technologies help to accelerate the
initiation of targeted antimicrobial therapy for patients with infections ... could potentially
extend the lifespan of current narrow- spectrum antimicrobials. Although conceptually new and
rapid AST technologies have been described, including new phenotyping methods, digital
imaging and genomic approaches, there is no single major, or broadly accepted, technological
breakthrough that leads the field of rapid AST platform development
Advising principles. The purpose of this document is to support competent authorities in charge of IHR implementation to improve national capacities for the prevention, detection ... control of events, by strengthening communications and coordination between points of entry and the national health surveillance system
From the start of the COVID-19 pandemic until August 2021, extreme weather events have affected at least 139.2 million people and killed at least 17,242 people in at least 433 unique events. These figures are certainly an underestimate, as they do n...
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging ... it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is no vaccine for the prevention of chikungunya fever. It has therefore become imperative to develop guidelines, based on the limited clinical experience gathered from managing patients so far, for appropriate management of patients in communities and in health facilities. Experts engaged in managing patients with chikungunya fever in the Region were brought together by the WHO Regional Office for South-East Asia to outline guidelines for managing various situations and stages of the disease.
The socioeconomic factors and public health inadequacies that facilitated the rapid spread of this infection continue to exist. As it is a new and emerging disease it has not received sufficient coverage yet in the medical curricula of Member States. Specific treatment is not available, and there is no vaccine for the prevention of chikungunya fever. It has therefore become imperative to develop guidelines, based on the limited clinical experience gathered from managing patients so far, for appropriate management of patients in communities and in health facilities. Experts engaged in managing patients with chikungunya fever in the Region were brought together by the WHO Regional Office for South-East Asia to outline guidelines for managing various situations and stages of the disease. This publication is the end result of that exercise and is intended to assist health-care providers in planning and implementing appropriate care to patients with chikungunya fever according to their actual clinical conditions
